Introduction
PET using labeled monoclonal antibodies, also known as immunoPET, shows promise as a tool to predict the outcome of cancer treatment based on monoclonal antibodies (1) . Their kinetics dictate the need for a positron label with a long half-life. An ideal radionuclide is 89 Zr (half-life, 78.41 h) because its physical half-life matches the biologic half-life of most antibodies. Additionally, it can easily and stably be coupled to monoclonal antibodies (2) . To date, all 89 Zr-monoclonal antibody PET/CT studies that have been reported were performed within a single centre (3) (4) (5) . More recently, several multicentre studies have been initiated. Multicentre studies with 18 F-labeled tracers have shown the need for standardization of image acquisition, reconstruction, and analysis procedures, such as outlined in the European Association of Nuclear Medicine guidelines for tumour imaging (6) and implemented in the form of an accreditation (EANM Research Ltd. [EARL] ). For 89 Zr, there are several additional factors that need to be considered: nonprompt emission of 909 keV γ rays after each positron emission may influence cross calibration between the local dose calibrator and the PET/CT camera, and low counting activity) may potentially lead to poorer image quality. The aim of this study was therefore to investigate the feasibility of quantitative accuracy and harmonized image quality in 89 Zr-PET/CT multicentre studies.
Materials and methods

Scanners
Three Gemini TF PET/CT scanners (Philips Healthcare) (7), a Biograph mCT PET/CT scanner (Siemens Medical Solutions) (8) , and a Discovery-690 PET/CT scanner (GE Healthcare) (9) were used in this study. Four of 5 PET/CT scanners were EARL-accredited before the start of this study.
89 Zr activity concentration measurements
After production of 89 Zr, a nonsticking solution was prepared for the phantom experiments. The solution consisted of 1 M oxalic acid neutralized with 2 M Na 2 CO 3 , diluted with 0.2 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid in phosphate buffer saline containing 1 mg⋅mL −1 of bovine serum albumin. All vials were measured in the central dose calibrator before delivery to the various PET centres, as well as in each local dose calibrator afterward. Assuming a homogeneous 89 Zr solution, injected activity in each phantom compartment was determined on the basis of measured net injected volume (derived from measurements of the weights of the syringes before and after injecting activity in the phantoms). In addition, local dose calibrator syringe measurements were performed to determine injected activity in each phantom compartment and compared with volume-based activity measurements.
Phantoms
A custom-made, homogeneous cylindric phantom (inner diameter, 29 cm; inner length, 20 cm) with a volume of 13.2 L was filled with an 89 Zr solution with an activity concentration of about 1 kBq⋅mL −1 . This phantom will be referred to as the cross calibration phantom. The 9.7-L background compartment of a National Electrical Manufacturers Association NU-2 image quality phantom (Data Spectrum) was filled with 0.7 kBq⋅mL −1 . This phantom contains 6 spheres with inner diameters of 10, 13, 17, 22, 28, and 37 mm. All spheres were filled with a sphere-to-background activity concentration of 10:1. This phantom will be referred to as the image quality phantom.
Acquisition and reconstruction protocols
A 10-min-per-bed-position 1-bed-position acquisition and a 5-min-per-bedposition 2-bed-position acquisition were obtained for the cross calibration and image quality phantoms, respectively. Data were normalized; corrected for decay, randoms, dead time, scatter, and attenuation; and reconstructed using settings (Table 3 .1) associated with EARL accreditation. The results of the present study were obtained on EARL-accredited scanners, as this accreditation program provides the most detailed specifications for harmonized quantitative performance (10) . All issues addressed in the present study, however, should also be applicable to other accreditation programs, as they are not fundamentally dependent on the specific accreditation program being followed.
Data analysis
Data were analyzed using software developed in-house. PET/CT calibration accuracy was defined as PET-measured activity divided by the activity measured in the central dose calibrator. Noise (%) was characterized by means of the coefficient of variation for a volume of interest (VOI) minimally 1 cm from the edge of the cross calibration phantom. Additional smoothing (Table 3 .1) was applied to match image noise. The image quality phantom was analyzed by calculating the recovery coefficient (RC) as a function of sphere size, being defined as the ratio of PET activity concentration to central dose calibrator activity concentration. VOI A50% was defined as VOI based on a 3-dimensional isocontour at 50% of the maximum voxel value with local background correction, VOI M ax was defined as VOI based on the voxel with the highest uptake, and VOI 3Dpeak was defined as VOI based on a spheric 1.2 cm diameter VOI positioned so as to maximize the enclosed average (11).
Results
Local dose calibrator activity measurements on the vials differed by up to 14% from central dose calibrator activity measurements. After correction for these differences, volume-based measurements coincided with syringebased ones within 6%. In Figure 3 .1, the accuracy of each PET scanner v relative to local dose calibrator and central dose calibrator measurements is shown. Based on central dose calibrator measurements, both the Discovery and the mCT scanners showed an accuracy within 3%, and the 3 Gemini scanners showed accuracies of 4%, 1%, and 10%. Figure 3 .2A shows that noise along the axial direction of the scans ranged from 13% to 25% in the centre. Images from the Gemini and Discovery systems were smoothed (Table 3 .1), and a comparable coefficient of variation of about 13% in the centre resulted for all images (Fig. 3.2B) . 
Discussion
This study assessed accuracy, noise, and RC characteristics for 89 Zr PET imaging with the goal of achieving accuracy and harmonized image quality in a multicentre setting.
Multicentre 89 Zr imaging essentially entails three additional steps for EARL-accredited scanners: calibration of the local dose calibrator for 89 Zr with respect to a common central dose calibrator; post-reconstruction smoothing of images derived from a Gemini or Discovery system; and use of VOI 3Dpeak for analysis of activity concentrations in lesions.
A limitation of the present study was the small sample size. However, information on image quality harmonization between scanners and institu- tions is already available (6) and has led to the EARL accreditation program, which aims to reduce this variation specifically for whole-body 18 F-FDG scanning in an oncology setting. Therefore, only additional issues specific to 89 Zr needed to be addressed. On the basis of existing EARL accreditation criteria, it seemed sufficient to include one current generation scanner from each of the main vendors and to perform a small number of repeated measurements on a scanner of a single vendor, as the impact of low counting statistics and nonprompt γ radiation may be assumed to be similar for similar types of PET/CT systems.
Cross calibration accuracy between the central dose calibrator and the PET/CT systems ranged from -3% to +10%, whereas use of individual uncalibrated local dose calibrators increased the variability (Fig. 3.1) . The largest inaccuracy (+10%) was shown for the nonEARL-accredited PET/CT scanner (Gemini 3). After calibration of the local dose calibrator to a central dose calibrator, volume-based syringe activity assessments agreed within 6% with local dose calibrator measurements. Therefore, clinical work can be based on local dose calibrator measurements, although for multicentre clinical trials, calibration of all local dose calibrators against a central dose calibrator is recommended. Noise levels ranged from 13% to 22% (central plane). The mCT showed the lowest coefficient of variation and a less curved profile. Because parameters such as injected activity, number of bed positions, and time per bed position were the same in all scanners, this observation may be attributed to the extended field of view of the mCT scanner and its associated higher sensitivity (Table 3 .1). Additional smoothing of the images from the other PET/CT systems was applied to obtain comparable noise levels in the central area of the cross calibration phantom (Fig.  3.2) . Because additional smoothing can downgrade image resolution, the effect of smoothing on RC was also investigated.
The use of VOI 3Dpeak resulted in a somewhat larger RC range than that obtained with VOI A50% . This can be explained, at least in part, by using a 1.2-cm fixed-size diameter for VOI 3Dpeak . For the largest spheres, RC with VOI A50% is based on larger volumes than is RC with VOI 3Dpeak , resulting in lower RC. The variability of RC among PET scanners was more prominent with VOI M ax because of the use of a single voxel for determining RC, associated with higher noise levels. A significantly lower RC variability was observed for VOI A50% and VOI 3Dpeak . A similar trend was observed for the additionally smoothed data. These observations are consistent with a previous study for 18 F-FDG (10). Another study (12) has shown that a large fixed-size square VOI may result in a poor estimate of standardized uptake value (SUV) response but only when metabolic tumour sizes decrease below 1 mL. Yet, a recent clinical study reported low variability for peak SUV (13) . Moreover, variability of RC based on VOI 3Dpeak was the smallest among VOI methods, consistent with a report (14) suggesting that VOI 3Dpeak may be more robust to changes in pixel size and image characteristics. SUV 3Dpeak may therefore be preferable for use in 89 Zr multicentre studies.
Conclusions
This study investigated the potential for performing quantitative multicentre 89 Zr PET/CT studies assuming harmonized data acquisition and reconstruction settings. After recalibration of the local dose calibrator to the central dose calibrator for 89 Zr, local activity measurements were accurate within 6%. After matching noise levels (∼13% at the centre of the cross calibration phantom), the use of VOI 3Dpeak resulted in ±7% variability in RC for each sphere across various PET/CT systems and imaging sites. The use of an 89 Zr calibration procedure in combination with SUV 3Dpeak in image analysis is recommended to be able to perform quantitatively accurate multicentre 89 Zr PET/CT studies with a harmonized image quality.
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